Association Between High-Sensitivity C-Reactive Protein Trajectories and the Incidence of Metabolic Syndrome:A Retrospective Cohort Study
JianJiang Pan,XiXuan Cai,JieRu Chen,MingYing Xu,JingYu Hu,YueChun Mao,Tao Chen,LuSha Li,MengQi Jin,LiYing Chen
DOI: https://doi.org/10.2147/jir.s493111
IF: 4.5
2024-11-09
Journal of Inflammation Research
Abstract:JianJiang Pan, 1, &ast XiXuan Cai, 1, &ast JieRu Chen, 1 MingYing Xu, 1 JingYu Hu, 1 YueChun Mao, 1 Tao Chen, 2 LuSha Li, 1 MengQi Jin, 1 LiYing Chen 1 1 Department of General Practice, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310020, People's Republic of China; 2 Department of General Practice, Jianqiao Community Health Service Center, Hangzhou, Zhejiang, 310021, People's Republic of China &astThese authors contributed equally to this work Correspondence: LiYing Chen, Department of General Practice, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China, Email Purpose: Understanding the role of systemic inflammation in the development of Metabolic Syndrome (MetS) is crucial for identifying individuals at a higher risk of this cluster of conditions that increase the risk of heart disease, stroke, and diabetes. Patients and Methods: A retrospective cohort study was conducted with 4,312 participants who were free from MetS at the study's onset and had high-sensitivity C-reactive protein (hsCRP) levels measured. Latent class trajectory modeling was utilized to identify distinct hsCRP trajectory patterns. Multivariable regression and proportional hazards analyses were employed to evaluate the predictive value of hsCRP trajectories for the development of MetS. Results: During the 1.63-year follow-up period, 1,308 participants developed metabolic syndrome (MetS). Individuals with high hsCRP levels exhibited a significantly increased risk of developing MetS compared to those with low hsCRP levels (HR = 1.062, 95% CI 1.103– 1.113). The hsCRP trajectory analysis identified three distinct groups: low-stable, increasing, and decreasing. The decreasing and increasing hsCRP trajectory groups demonstrated a 1.408-fold (95% CI 1.115– 1.779) and a 1.618-fold (95% CI 1.288– 2.033) increased risk of MetS, respectively. Conclusion: This study suggests that participants with higher baseline hsCRP levels and increasing hsCRP trajectories are associated with a progression toward MetS. Long-term hsCRP trajectories may serve as useful tools for identifying individuals at higher risk of MetS who could benefit from targeted preventive and therapeutic interventions. Keywords: high-sensitivity C-reactive protein, metabolic syndrome, trajectory analysis, retrospective cohort study, risk prediction Metabolic syndrome (MetS) is a cluster of interconnected metabolic conditions, including central obesity, dyslipidemia, hypertension, and hyperglycemia, that collectively elevate the risk of cardiovascular disease, stroke, and type 2 diabetes mellitus. 1 The prevalence of MetS has been rising globally, driven by lifestyle factors such as poor diet, physical inactivity, and increasing rates of obesity. 1,2 In China, this trend is reflected in the high and increasing prevalence rates. According to recent studies, the prevalence of MetS among Chinese adults has reached 33.9%, estimating that 450 million people in China are affected by MetS. 3 Given its significant public health implications, understanding the underlying mechanisms and identifying predictive biomarkers for MetS are of paramount importance. High-sensitivity C-reactive protein (hsCRP), an acute-phase protein produced by the liver in response to inflammatory stimuli, has emerged as a robust biomarker for systemic inflammation. 4 This inflammatory response is intricately linked to key components of metabolic syndrome (MetS), including insulin resistance and central obesity. 5 A multitude of cohort studies have established a direct correlation between elevated CRP levels and the development of MetS, as well as the subsequent risk of cardiovascular diseases. 6,7 Notably, studies conducted across mainland Asia and Europe have found that higher hsCRP levels are associated with a heightened risk of developing MetS among adults from China, 8 Japan, 9 Korea. 10 Despite extensive research, there remains a need for longitudinal studies that explore how changes in hsCRP levels over time relate to the risk of developing MetS. Trajectory analysis, a statistical technique that identifies distinct patterns of change within a population, has been widely applied to various health outcomes, including depressive symptoms, peripheral artery disease, and arterial stiffness 11,12 . This method provides a powerful approach to uncovering the dynamic nature of high-sensitivity C-reactive protein (hsCRP) and its association with the risk of metabolic syndrome (MetS). This -Abstract Truncated-
immunology